首页> 外文期刊>Journal of Clinical and Diagnostic Research >Mortality Rates of EUS-Guided Biliary Drainage (EUS-BD) in Malignant Biliary Obstruction Patients in EUS-BD Era versus Non-EUS-BD Era: A Retrospective Cohort Study
【24h】

Mortality Rates of EUS-Guided Biliary Drainage (EUS-BD) in Malignant Biliary Obstruction Patients in EUS-BD Era versus Non-EUS-BD Era: A Retrospective Cohort Study

机译:EUS-BD ETA恶性胆道阻塞患者的令人毛炎胆道引流(EUS-BD)的死亡率与非EUS-BD时代的恶性胆道阻塞患者:回顾性队列研究

获取原文
           

摘要

Most of the Cholangiocarcinoma (CCA) patients are commonly found in an advanced stage and often presents with Malignant Biliary Obstruction (MBO).Palliative treatment using biliary drainage plays a major role in the treatment modalities.However, only a few studies with small number of subjects have reported their long term outcomes.Aim: To compare the mortality rates of MBO patients in Endoscopic Ultrasound-guided Biliary Drainage (EUS-BD) era versus non-EUS-BD era.Materials and Methods: The present study was a retrospective cohort study which enrolled 132 MBO patients who had received palliative treatment between January 2014 to August 2020 at Thabo Crown Prince Hospital, Nong Khai, Thailand.The patients were treated either with EUS-BD (group l, n=30) or non-EUS-BD (group ll, n=94).Due to imbalance of follow-up time between two groups, the Overall Survival (OS) rates were compared using parametric survival analysis with restricted mean difference at 12 months follow-up, adjusted by other covariates, and presented in term of Kaplan-Meier curve, Hazard Ratio (HR) and 95% confidence interval.Results: Most of the patients (99.19%) were having CCA.The clinical characteristics between the two groups showed no significant difference, except the mean follow-up time that group II was shorter than group I (2.43 vs.7.12 months; p<0.001).At 12 months after treatment, the OS rate of group I remained significantly higher than group II (mean difference=2.23; 95%CI: 0.54-3.92; p=0.010).The parametric-Cox proportional hazard model showed that the 1-year mortality of patients in group I were 63% less than those in group II, the parametric model between two groups showed statistical significance with p-value=0.043.Conclusion: From present study it can be concluded that EUSBD in MBO patients achieves lower mortality rate at one year follow-up.For conclusive findings of the benefit of EUS-BD, a prospective long term study with larger numbers of subjects should be performed.
机译:大多数胆管癌(CCA)患者常见于先进的阶段,通常具有恶性胆道阻塞(MBO)。使用胆道引流的可汗性治疗在治疗方式中起主要作用。但是,只有少数研究受试者报告了他们的长期成果。优雅:为了比较内镜超声引导胆道引流(EUS-BD)时代的MBO患者的死亡率与非EUS-BD时代。材料和方法:本研究是回顾性队列注册了132名MBO患者,在2014年1月至2020年到2020年在Thabo Crown王子医院,Nong Khai,Nong Khai,泰国患者。患者用EUS-BD(L,N = 30)或非eus- BD(组LL,N = 94)。在两组之间的后续时间不平衡,使用参数存活分析进行比较总存活(OS)率,其在12个月随访时具有限制平均差异,由OT调整她的协变量,并以Kaplan-Meier曲线,危险比(HR)和95%的置信区间呈现。结果:大多数患者(99.19%)具有CCA。两组之间的临床特征显示出没有显着差异,除了第II组的平均随访时间短于I群(2.43 vs.7.12个月; P <0.001)。治疗后12个月,I族的OS率明显高于II族(平均差异= 2.23; 95%CI:0.54-3.92; P = 0.010)。参数 - COX比例危险模型显示患者1年的死亡率低于II组的63%,两组的参数模型显示出与p值= 0.043的统计学意义。结论:从现在的研究中可以得出结论,eusbd在mbo中可以得出结论患者在一年后达到死亡率降低。对于EUS-BD的福利的确凿调查结果,应当进行较大数量的受试者的预期长期研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号